Jacobs Levy Equity Management’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-21,530
Closed -$362K 1078
2021
Q3
$362K Buy
21,530
+7,982
+59% +$134K ﹤0.01% 911
2021
Q2
$207K Buy
+13,548
New +$207K ﹤0.01% 983